Rifaximin anti-rectal dysfunction preparation

Details for Australian Patent Application No. 2007223881 (hide)

Owner Salix Pharmaceuticals, Inc.

Inventors Safdi, Alan; Taylor, David

Agent Pizzeys

Pub. Number AU-A-2007223881

PCT Pub. Number WO2007/103448

Priority 60/781,144 09.03.06 US; 60/791,236 11.04.06 US

Filing date 6 March 2007

Wipo publication date 13 September 2007

International Classifications

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Event Publications

18 September 2008 PCT application entered the National Phase

  PCT publication WO2007/103448 Priority application(s): WO2007/103448

8 January 2009 Alteration of Name

  The name of the applicant has been altered to Salix Pharmaceuticals, Inc.; Safdi, A.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007223885-Multipurpose support pillow

2007223880-A method for the preparation of recombinant human thrombin and fibrinogen